PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 30 mg vial with 2 mL of sterile water for injection, what concentration do I end up with?

Asked 11 Dec 2025Modified 6 months agoViewed 8.7k times
12

What I have: 30 mg · 2 mL · sterile water for injection.

I can do the algebra. I am not confident about the conversion factors.

If there is a standard way to lay this out, I would rather learn that than invent one.

What is the general form of this calculation?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
sterile-water
sterile-water

Preservative-free sterile water for injection: appropriate for a single-withdrawal presentation, a poor choice for anything you intend to open…

35 questions
shareeditfollowflag
BA
askedben_akintola10k1611 Dec 2025

1 Answer

Sorted by votes
8

30 ÷ 2 = 15 mg/mL. Concentration is vial content divided by diluent volume, so 30 mg of peptide in 2 mL of sterile water for injection gives 15 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.15 mg — 150 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.

Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.

The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

On the detail: photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.

The caveat on all of this is that it assumes the vial contains what the label says.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

edited 7 Feb 2026 by rota_site — removed a claim I could not source

shareimprove this answerflag
RS
answeredrota_site36k2722 Jan 2026
This should be linked from the help pages. – dermot_kiely 6 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.